| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8949945 | Pathology - Research and Practice | 2018 | 20 Pages |
Abstract
Our study suggests that Acer3 contributes to HCC propagation, and suggests that inhibition of Acer3 may be novel strategy for treating human HCC.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Yancun Yin, Maolei Xu, Ju Gao, Minjing Li,